New Lenses Incorporate CooperVision’s Proven Biofinity® toric Lens Design and Most Advanced Material
PLEASANTON, Calif., January 2, 2018 — Combining the world-renowned design features of Biofinity® toric with the Smart Silicone™ chemistry of MyDay®, CooperVision, Inc. announced today the introduction of MyDay® toric daily disposable contact lenses in the United States.
The new addition to CooperVision’s premium silicone hydrogel 1-day lens family brings together everything that practitioners and astigmatic patients need for an unprecedented 1-day experience: the healthy advantages of silicone hydrogel,1 uncompromised comfort and handling, and excellent lens stability and visual acuity. In a clinical study, eye care professionals observed better overall stability with MyDay® toric compared to 1-Day Acuvue® Moist® for Astigmatism.
MyDay® toric features the same groundbreaking Optimized Toric Lens Geometry™ found in Biofinity® toric, providing uniform horizontal ISO thickness, an optimized ballast band design, large toric optic zone, and a smooth, continuous surface to make it an easy-to-fit,2 stable toric lens. Biofinity® toric is a proven lens that keeps doctors and patients satisfied; over the last 18 months, more than 93% of Biofinity® toric wearers in the U.S. remained in the brand.3 This represents the greatest retention of any brand on the market.
In addition, the MyDay® family of lenses is made with Smart Silicone™ chemistry, an innovative technology that delivers a hybrid of benefits—the best of both hydrogel and silicone hydrogel lenses. Smart Silicone™ chemistry optimizes oxygen permeability in a lens that is just 4.4% silicon—the lowest percentage of silicon found in a silicone hydrogel, 1-day lens. By using less silicon, Smart Silicone™ chemistry leaves more room in the lens for hydrophilic (water loving) material, resulting in improved surface wettability, higher water content, and lower modulus for a softer, more comfortable lens-wearing experience. It also enables a modulus of only 0.4 MPa to make MyDay® CooperVision’s softest ever 1-day silicone hydrogel contact lens. And while the lens provides the optimal softness of a hydrogel, it remains strong enough to ensure the exceptional handling of a silicone hydrogel lens.
“Ever since we brought MyDay® to market in 2015, eye care professionals have been asking when we would follow with MyDay® toric,” said Michele Andrews, Senior Director of Professional and Academic Affairs, North America, CooperVision. “We worked alongside them, listened to their needs, and are excited to place this lens in their hands. MyDay® toric provides practitioners the trusted Biofinity® toric design features with the advanced technology of our premium 1-day lens—it’s the best of both worlds.”
MyDay® toric further expands CooperVision’s 1-day portfolio, with practitioners able to select from the MyDay®, clariti® 1 day and Proclear® 1 day families of 1-day lenses to provide exceptional options for just about every eye.
“Eye care professionals now have the ability to significantly enhance their patients’ 1-day wearing experience when upgrading to MyDay® toric from a 1-day toric hydrogel,” said Dr. Andrews.
Testing shows that MyDay® toric not only offers immediate comfort at insertion, but has excellent comfort over the course of the day. The MyDay® family of lenses is naturally wettable, without coatings or surface treatments. Built-in UV protection filters 85% of UVA and 96% of UVB rays,4 helping support long-term ocular health.
MyDay® toric lenses are currently available in sphere powers from plano to -6.00D (0.25D steps), and -6.00 to -10.00D (0.50D steps), with cylinder options of -0.75D, -1.25D, and -1.75D in axes of 10°, 20°, 70°, 80°, 90°, 100°, 110°, 160°, 170°, and 180° and -2.25 in axes of 10°, 20°, 90°, 160°, 170°, and 180°. Plus powers will be added soon. MyDay® toric lenses have a base curve of 8.6mm and a diameter of 14.5mm.
For more information, visit PrescribeMyDay.com/toric.
1 With higher oxygen permeability than hydrogel materials, silicone hydrogel contact lenses minimize or eliminate hypoxia-related signs and symptoms during lens wear.
2 Results based on 144 participating eye care professionals in a multi-national online survey. 2016.
3 Q3 2017 U.S. industry data on file
4 Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.
About CooperVision
CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 11,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Media Contact
Heather Kowalczyk, APR
McDougall Communications for CooperVision
(585) 330-4878